ACADIA Pharmaceuticals
ACAD
#4041
Rank
HK$24.17 B
Marketcap
HK$139.85
Share price
-2.67%
Change (1 day)
-24.51%
Change (1 year)

Market capitalization of ACADIA Pharmaceuticals (ACAD)

Market cap: HK$24.17 Billion

As of November 2026 ACADIA Pharmaceuticals has a market cap of HK$24.17 Billion. This makes ACADIA Pharmaceuticals the world's 4041th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ACADIA Pharmaceuticals from 2004 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$24.17 B-31.71%
2025HK$35.39 B49.03%
2024HK$23.74 B-40.84%
2023HK$40.14 B99.32%
2022HK$20.14 B-31.15%
2021HK$29.25 B-55.59%
2020HK$65.88 B27.35%
2019HK$51.73 B184.01%
2018HK$18.21 B-37.66%
2017HK$29.21 B7.88%
2016HK$27.08 B-3.84%
2015HK$28.16 B14.32%
2014HK$24.63 B39.56%
2013HK$17.65 B567.9%
2012HK$2.64 B496.78%
2011HK$0.44 B20.53%
2010HK$0.36 B-6.33%
2009HK$0.39 B51.73%
2008HK$0.25 B-91.91%
2007HK$3.19 B56.17%
2006HK$2.04 B59.1%
2005HK$1.28 B45.16%
2004HK$0.88 B

End of Day market cap according to different sources

On Nov 18th, 2026 the market cap of ACADIA Pharmaceuticals was reported to be:

HK$24.17 Billion
by Nasdaq info icon info icon
HK$24.17 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
HK$5.149 T 21,203.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$1.254 T 5,090.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$9.661 T 39,869.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$954.94 B 3,850.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
HK$1.77 B-92.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Adamas Pharmaceuticals
ADMS
HK$2.95 B-87.79%๐Ÿ‡บ๐Ÿ‡ธ USA